Concepedia

Julius A Vaz

JA

Statistics

Publications

2

Citations

119

H-Index

2

Active since

2003

Affiliations

Novo Nordisk (Denmark)(Current)

Julius A Vaz is an author at Novo Nordisk (Denmark) specializing in diabetes pharmacotherapy, endocrinology, and pharmacotherapy.

Publications per year

2003–2004

2

Publications

2

Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes

Bernhard O. Boehm, Julius A Vaz, Lise Brøndsted et al. · European Journal of Internal Medicine · 2004 · 98 citations

, , +14

Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy

Itamar Raz, Ulrik Mouritzen, Julius A Vaz et al. · Clinical Therapeutics · 2003 · 21 citations

, , +15

1–2 of 2